Claim Ownership

Author:

Subscribed: 0Played: 0
Share

Description

 Episodes
Reverse
This episode introduces new podcast cohosts Amy LaLonde and Christina Nurse!  They take over hosting duties starting with Episode 101.
James Buchanan, Judy Li, Melvin Munsaka, and Bill Wang discuss the research of the Safety Scientific Working Group and their recent edited volume "Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches."  https://tinyurl.com/2ucyer95
Devan discusses the 5-STAR methodology and endpoints for COVID vaccine clinical trials.
Alan is the 2022 Chair of the Biopharmaceutical Section. He discusses his wish list for things to accomplish this year.
 Anna Nevius reflects on her time at the Center for Veterinary Medicine at the FDA and as chair of the Biopharmaceutical Section in 2009.
Bob Starbuck reflects on his time as chair of the Biopharmaceutical Section in 1994.
Amy Xia and Lanju Zhang discuss the benefits and challenges of utilizing external control arms for clinical trials.
Bo Huang and Gene Pennello discuss the 2021 Regulatory-Industry Statistics Workshop.
Joseph Cappelleri and Daniel O’Connor discuss the benefits and challenges in using patient reported outcomes and how to appropriately define clinically-meaningful change.
Haoda Fu, Mengling Liu, Jie Tang, Tian Zheng, and Kelly Zou discuss leadership and the impact of COVID-19 on the workplace.
Episode 89: Karl Peace

Episode 89: Karl Peace

2021-05-3147:43

Karl Peace was chair of the Biopharmaceutical Section in 1990. He discusses his career in the industry, the Jiann-Ping Hsu College of Public Health, and the Biopharmaceutical Applied Statistics Symposium.
Katherine Monti was chair of the Biopharmaceutical Section in 2010. She discusses her career in the industry and how the Section has changed over time. 
Episode 87: Storytelling

Episode 87: Storytelling

2021-03-3101:04:59

Scott Evans, Stephanie Omokaro, Janet Wittes, and Zhiheng Xu discuss the importance of storytelling for the modern statistician. 
Meg Gamalo and Jingjing Ye talk about pediatric drug development and discuss why forming a scientific working group was so important.
Episode 85: Weili He

Episode 85: Weili He

2021-01-2940:52

Weili talks about publishing, leadership, and her hopes and plans for the Biopharmaceutical Section in 2021.
David shares some of his experiences as the first statistician ever hired at Pfizer.
Kerry Go and Elaine Hoffman discuss vaccine development.
Olga and Natallia discuss their new book Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications. 
This episode features discussions with 3 mentor-mentee pairs from the Biopharmaceutical Section mentoring program. Conversations include Qing Li and Abie Ekangaki (start 1:25), Samson Ghebremariam and Scott Clark (start 44:33), and Carie Kimbrough and Bruce Binkowitz (start 102:29). They discuss the benefits of mentoring and the dynamics of the mentoring relationship. 
Yabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual.
Comments 
loading
Download from Google Play
Download from App Store